SUBSCRIBE
SUBSCRIBE
News   Business

Javelin Pharmaceuticals Reports Third Quarter 2009 Results

November 10, 2009 | 
1 min read

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV), a leading developer of novel acute care pain products, today reported its unaudited financial results for the third quarter ended September 30, 2009.

Earnings
MORE ON THIS TOPIC
Concept of money prize. Vector illustration. Halftone hand holds bouquet of money flowers. Gift prize, donation, earnings, bonus or cashback concept. Retro poster or banner. Creative trend collage.
Manufacturing
Samsung Biologics Continues Mega-Deal Streak With $1.4B European Contract
January 23, 2025
 · 
2 min read
 · 
Tristan Manalac
Oct 9, 2019 Milpitas / CA / USA - Johnson & Johnson Vision offices in Silicon Valley; Johnson & Johnson Vision Care, Inc. is part of the American multinational corporation Johnson&Johnson
Earnings
J&J Says Deals Likely to Shrink After $14.6B Intra-Cellular Buy
January 22, 2025
 · 
3 min read
 · 
Annalee Armstrong
Business people shaking hand in China.
ADCs
ArriVent Joins Chinese Licensing Trend With Potential $1.2B+ ADC Deal with Lepu
January 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Large yellow signboard on metal frame with the word IPO. Clear sky in the background. Concept of share trading on stock market, capital investment, currency exchange
IPO
Chinese Biotech Ascentage Aims For $134M IPO
January 22, 2025
 · 
2 min read
 · 
Tristan Manalac